Benefit and Risk Assessment for Off-label(English)
- many drugs that are relevant to children are not licensed for use in this population implying that a thorough assessment of risks and benefits in the pediatric population has not been made at all, implying a negative risk-benefit balance in children, or implying insufficient information to establish the risk-benefit balance
- INN, MA, OLP
- Pediatrics, Pharmacology / pharmaceutics, Adverse effect
- https://doi.org/10.1002/cpt.2336